Megren H. A. Fagihi

Megren H. A. Fagihi

Auto-generated profile, based on publicly available information

Megren H. A. Fagihi

School of Medicine, University College Dublin, Belfield, Dublin 4, Ireland

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2022 in ACS Pharmacology & Translational Science
Verified
Journal Article
Open access
MFMegren H. A. Fagihi
Megren H. A. Fagihi
Sourav BhattacharjeeSourav Bhattacharjee
Sourav Bhattacharjee
Insulin is a therapeutically relevant molecule with use in treating diabetes patients. Unfortunately, it undergoes a range of untoward and often unpredictable physical transformations due to alterations in its biochemical environment, including pH, ionic strength, temperature, agitation, and exposure to hydrophobic surfaces. The transformations are prevalent in its physiologically active monomeric form, while the zinc cation-coordinated hexamer, although physiologically inactive, is stable and less susceptible to fibrillation. The resultant molecular reconfiguration, including unfolding, misfolding, and hydrophobic interactions, often results in agglomeration, amyloid fibrillogenesis, and precipitation. As a result, a part of the dose is lost, causing a compromised therapeutic efficacy. Besides, the amyloid fibrils form insoluble deposits, trigger immunologic reactions, and harbor cytotoxic potential. The physical transformations also hold back a successful translation of non-parenteral insulin formulations, in addition to challenges related to encapsulation, chemical modification, purification, storage, and dosing. This review revisits the mechanisms and challenges that drive such physical transformations in insulin, with an emphasis on the observed amyloid fibrillation, and presents a critique of the current amelioration strategies before prioritizing some future research objectives.

6 July 2023 in ACS Omega
Verified
Journal Article
Open access
MFMegren H. A. Fagihi
Megren H. A. Fagihi
CPChanaka Premathilaka
Chanaka Premathilaka
TOTiina O’nEill
Tiina O’nEill
MGMassimiliano Garré
Massimiliano Garré
Sourav BhattacharjeeSourav Bhattacharjee
Sourav Bhattacharjee
Insulin undergoes agglomeration with (subtle) changes in its biochemical environment, including acidity, application of heat, ionic imbalance, and exposure to hydrophobic surfaces. The therapeutic impact of such unwarranted insulin agglomeration is unclear and needs further evaluation. A systematic investigation was conducted on recombinant human insulin-with or without labeling with fluorescein isothiocyanate-while preparing insulin suspensions (0.125, 0.25, and 0.5 mg/mL) at pH 3. The suspensions were incubated (37 °C) and analyzed at different time points (t = 2, 4, 24, 48, and 72 h). Transmission electron microscopy and nanoparticle tracking analysis identified colloidally stable (zeta potential 15 ± 5 mV) spherical agglomerates of unlabeled insulin (100-500 nm). Circular dichroism established the preservation of insulin's secondary structure rich in α-helices despite exposure to an acidic environment (pH 3) for 72 h. Furthermore, fluorescence lifetime imaging microscopy illustrated an acidic core inside these spherical agglomerates, while the acidity gradually lessened toward the periphery. Some of these smaller agglomerates fused to form larger chunks with discrete zones of acidity. The data indicated a primary nucleation-driven mechanism of acid-induced insulin agglomeration under physiologically relevant conditions.

31 October 2025 in RSC Advances
Verified
Journal Article
Open access
PDF file
MFMegren H. A. Fagihi
Megren H. A. Fagihi
YLYuchan Lee
Yuchan Lee
BHBridget Hogg
Bridget Hogg
MGMassimiliano Garre'
Massimiliano Garre'
Sourav BhattacharjeeSourav Bhattacharjee
Sourav Bhattacharjee
An in vitro study was conducted to investigate the cellular uptake and compartmentalization of internalized insulin in human hepatocellular carcinoma-derived HepG2 cells using confocal laser scanning microscopy. The cellular nuclei and actin filaments were stained with Hoechst (λex = 405 nm, λem = 415–485 nm) and Alexa Phalloidin 647 (λex = 649 nm, λem = 658–775 nm) dyes, respectively. Besides, recombinant human insulin, labeled with fluorescein isothiocyanate (λex = 491 nm, λem = 502–600 nm), was used for the uptake studies (37 °C) at a concentration of 0.5 mg mL−1, with timepoints at 15 min and 30 min. The optimized tri-staining protocol proved adequate for confocal microscopy, while the 2D and 3D renditions revealed insulin uptake by HepG2 cells. The internalized (fluorescent) insulin was taken up into vesicles (receptor-mediated endocytosis) and spread throughout the cytoplasm, with little or no interaction with the actin network. Some of the internalized insulin accessed the cellular nuclei. Such nuclear interaction might explain insulin's role in influencing translation, cellular proliferation, and (overall) growth. The study developed an optimized tri-staining procedure that enabled in-depth visualization of HepG2 cells (actin network and nuclei) with internalized insulin, providing a better understanding of insulin's cellular uptake and nuclear interaction.